Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
The Journal of Nutrition|September 18, 2009
Trans-11 vaccenic acid reduces hepatic lipogenesis and chylomicron secretion in JCR:LA-cp ratsYe Wang, M Miriam Jacome-Sosa, Megan R Ruth, et al.
The Yale Journal of Biology and Medicine|November 26, 2015
Taking Control of Castleman Disease: Leveraging Precision Medicine Technologies to Accelerate Rare Disease ResearchSamantha Kass Newman, Raj K Jayanthan, Grant W Mitchell, et al.
Breast Cancer Research : BCR|June 5, 2021
Cellular dormancy in minimal residual disease following targeted therapyJason R Ruth, Dhruv K Pant, Tien-Chi Pan, et al.
Plos One|June 27, 2019
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman diseaseChristopher S Nabel, Stephen Sameroff, Dustin Shilling, et al.
Frontiers in Nutrition|October 26, 2016
Mechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat StrainAbdoulaye Diane, W David Pierce, Sandra E Kelly, et al.
Science (New York, N.Y.)|February 26, 2016
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cellsGregory V Kryukov, Frederick H Wilson, Jason R Ruth, et al.
The Journal of Clinical Investigation|August 14, 2019
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman diseaseDavid C Fajgenbaum, Ruth-Anne Langan, Alberto Sada Japp, et al.
Blood Advances|August 26, 2021
Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman diseaseSheila K Pierson, Sushila Shenoy, Ana B Oromendia, et al.
Pageof 8